Lemmy Today

1,462 readers
92 users here now

Welcome to lemmy.today!

About us

🤗 Thanks for joining our little instance here, located in Oregon. The idea is to have a fast, stable instance and allow users to subscribe to whatever content they want from here.

😎 We dont block any other instances. We will keep it that way unless it becomes a moderation problem.

🤠 We will be around for a very long time, so you dont have to worry about us shutting down the instance anytime soon. We like performance and stability in our servers, and will upgrade the instance when its needed.

🥹 Make sure to join a lot of remote communities to get a good feed going. How to do that is explained here.

Lemmy mobile apps

You should start using one of these ASAP since the web browser user interface is quite ugly, even with themes.

Sync for Lemmy (Android)
Boost for Lemmy (Android)
Eternity (Android)
Liftoff (Android and IOS)
Voyager (IOS)
Voyager WebApp
Jerboa (Android)
Connect (Android)
Thunder (Android and IOS)
Mlem (IOS)
Memmy (IOS)

Optional Lemmy web browser user interfaces

Rules

Be respectful. Everyone should feel welcome here.
No bigotry - including racism, sexism, ableism, homophobia, transphobia, or xenophobia.
No Ads / Spamming, or creating communities to promote blogs or services.
No local pornography communities (but you are free to subscribe to them on other instances if you wish).
No local communities about software related to porn.
No local religious communities (use remote ones)

Contact the admin

@mrmanager

founded 1 year ago

ADMINS

mrmanager

Buelldozer

Moderna’s mRNA cancer vaccine works even better than thought (www.freethink.com)

submitted 7 months ago* (last edited 7 months ago) by MicroWave@lemmy.world to c/health@lemmy.world

4 comments fedilink

Adding Moderna’s in-development cancer vaccine to a standard treatment for melanoma dramatically reduces cancer survivors’ risk of death or recurrence, according to newly shared trial data.

…

Moderna and pharma giant Merck are developing an mRNA-based cancer vaccine, mRNA-4157 (V940), for people who’ve had high-risk melanomas removed.

The vaccine works by instructing the body to make up to 34 “neoantigens.” These are proteins found only on the cancer cells, and Moderna personalizes the vaccine for each recipient so that it carries instructions for the neoantigens on their cancer cells.

The idea behind the vaccine is that, by prompting the body to make these proteins, it can prepare the immune system to quickly identify and attack any new cancer cells bearing them, preventing recurrence.

What’s new? In the ongoing phase 2b KEYNOTE-942 study, Moderna and Merck are comparing the cancer vaccine’s ability to prevent melanoma recurrence or death when combined with Keytruda, Merck’s FDA-approved cancer treatment, to Keytruda alone.